key: cord-0851519-tmgj692r authors: Galeazzi, Gian Luca; Loffi, Marco; Di Tano, Giuseppe; Danzi, Gian Battista title: Severe COVID-19 Pneumonia and Very Late Stent Thrombosis: a Trigger or Innocent Bystander? date: 2020-05-18 journal: Korean Circ J DOI: 10.4070/kcj.2020.0166 sha: 28aced9876c895003c06653b7ddc52221332d9fc doc_id: 851519 cord_uid: tmgj692r nan lesion of the proximal right coronary artery, that was immediately treated (Figure 1B) . A severe bilateral pneumonia was documented at chest X-ray and confirmed at computed tomography ( Figure 1C and D) . Nasopharyngeal swab tested positive for coronavirus disease 2019 (COVID-19) infection. Arterial blood gas analysis on oxygen therapy showed severe hypoxemia with a PaO 2 /FiO 2 ratio of 100. The patient was treated with noninvasive ventilation but died a few hours later of severe acute respiratory distress syndrome. Patients with chronic coronary artery disease have an increased probability of developing an acute coronary syndrome (ACS) during acute infections. 1) COVID-19 may affect the cardiovascular system in multiple ways and these mechanisms can interact each other: direct myocardial involvement mediated via angiotensin-converting enzyme 2 2) ; hypoxemia due to severe COVID-19 infection 3) ; cytokines storm and high concentrations of inflammatory mediators that could lead to atherosclerotic plaque instability and rupture 4) ; repeated floods of catecholamines due to anxiety. 5) This case of diffuse COVID-19 pneumonia seems to confirm the role of severe infection as a precipitating factor for ACS in patients with chronic coronary artery disease, and causal relationship. Risk of myocardial infarction and stroke after acute infection or vaccination SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS COVID-19 and the cardiovascular system Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Role of psychotropic medications in the treatment of adults with